Your landing page’s weakest score is Trust.
How Certara (CoAuthor) ranks
58Growth scoreupdated
category scores
category scoresShowHide
Trust
44PoorProof that the product is real, competent, and safe to try.
| Trust read | |
|---|---|
| Certara (CoAuthor) | "Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit" news card |
| Logo strip with Merck, Sanofi, Bristol Myers Squibb, Johnson & Johnson, Stanford, and MIT | |
| Customer logo strip: Bayer, GSK, Lilly, Novartis, Pierre Fabre, Sanofi | |
| Press Release: Weave Bio Announces Collaboration with Takeda | |
| "Trusted by 250,000+ independent businesses" ticker above the headline |
Value props
58FairTitle, subtitle, hero — do they sell the product's true value?
Certara (CoAuthor)’s headline vague
Transforming drug discovery and development for good
Drug development must change today to meet the demands of speed, innovation, and efficiency essential for creating the drugs of tomorrow. Certara empowers this evolution with predictive simulation, data-driven modeling, and AI tailored for
Working
- Names real methods: simulation, modeling, AI
- "Make Certara (CoAuthor)'s drug a reality" hits the core hope
- "Decades of expertise" adds credibility
Could improve
- Headline is a mission, not a value prop
- Zero numbers or proof points in fold
- Hero image decorates, shows nothing
Mobile web
58FairThe phone experience as a first-class citizen.
What works
What to improve
CTA
62FairCopy, size, verb, cost-feel — does the primary CTA earn the click?
How Certara (CoAuthor) compares
Recommended rewrites
Information hierarchy
70FairDoes the design help or inhibit what the page is trying to say?
What works
What to improve